Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ORAGENICS INC Director's Dealing 2014

Oct 31, 2014

35380_dirs_2014-10-31_2f2ce6c1-f152-46f1-9edf-1c10b22f5373.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORAGENICS INC (OGEN)
CIK: 0001174940
Period of Report: 2014-10-30

Reporting Person: Sullivan Michael O'Keefe (CFO, Secretary and Treasurer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-10-30 Employee Stock Option (Right to Buy) $0.86 A 25000 Acquired 2024-10-30 Common Stock (25000) Direct

Footnotes

F1: Issuance of stock options to Mr. Sullivan in connection with service to the Company as Interim Principal Executive Officer pursuant to the 2012 Equity Incentive Plan. These shares vest six months from the date of grant.